Process for treating fibroses with biocompatible polymer

Details Process for treating fibroses with biocompatible polymer Process for treating fibroses with biocompatible polymer

2011-08-16

2011-08-16

Ford, Allison M. (Department: 1651)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Reexamination Certificate

active

07998922

ABSTRACT:
A biocompatible polymer constituted by a sequence of identical or different components of the general formula (I): AaXxYy, in which A represents a monomer, X represents a carboxyl group fixed on a monomer A, Y represents a sulfate or sulfonate group fixed on a monomer A; a represents the number of monomers A, x represents the substitution rate of the set of monomers A by the groups X, y represents the substitution rate of the set of monomers A by the groups Y. The invention also pertains to the pharmaceutical or diagnostic compositions containing at least one polymer of general formula (I).

REFERENCES:
patent: 3762924 (1973-10-01), Morii et al.
patent: 3907755 (1975-09-01), Margraff et al.
patent: 4740594 (1988-04-01), Mauzac et al.
patent: 4755379 (1988-07-01), Jozefonvicz et al.
patent: 4931553 (1990-06-01), Gill et al.
patent: 4935338 (1990-06-01), Masuda et al.
patent: 5314881 (1994-05-01), Rapisarda
patent: 5693625 (1997-12-01), Barritault et al.
patent: 5852003 (1998-12-01), Barritault et al.
patent: 5852004 (1998-12-01), Barritualt et al.
patent: 6517824 (2003-02-01), Kohn et al.
patent: 6573251 (2003-06-01), Barritualt et al.
patent: 1 231 334 (1988-01-01), None
patent: 1152 396 (1963-08-01), None
patent: 62 514 (1967-04-01), None
patent: 1 572 267 (1971-01-01), None
patent: 25 156 (1984-01-01), None
patent: 0 066 283 (1982-12-01), None
patent: 0 168 277 (1986-01-01), None
patent: 0 450 398 (1991-10-01), None
patent: 0 557 887 (1993-09-01), None
patent: 894508 (1944-12-01), None
patent: 2 461 724 (1981-02-01), None
patent: 2 644 066 (1990-09-01), None
patent: 2 718 023 (1995-10-01), None
patent: 2 718 024 (1995-10-01), None
patent: 2 718 025 (1995-10-01), None
patent: 2 718 026 (1995-10-01), None
patent: 49-48785 (1974-11-01), None
patent: 61-9431 (1986-01-01), None
patent: 2-231075 (1990-09-01), None
patent: 5-313295 (1993-11-01), None
patent: 2000-516971 (1998-01-01), None
patent: 10-501568 (1998-02-01), None
patent: 2000-516211 (2000-12-01), None
patent: 328094 (1970-05-01), None
patent: 95/26739 (1995-10-01), None
patent: 95/34595 (1995-12-01), None
patent: 98/03572 (1998-01-01), None
patent: 98/03573 (1998-01-01), None
K.W. Walton et al.,The Histochemical Basis of Metachromasia(1954) Brit. J. Exptl. Pathol., 227-40, (in CAPLUS, AN 1954:78020).
C.H. Rückardt et al.,Pathological and Anatomical Findings After Administration of Dextran Sulfate and Carboxymethyl Dextran Sulfates in Experimental Animals(1963) Acta Biol. Med. Ger., 10, 126-46.
F. Gensicke et al.,Microdistribution of Radio Sulfur in Rabbits After Intravenous Injection of 35S-Labeled Dextran and Carboxymethyl Dextran Sulfates(1965) Acta Biol. Med. Ger., 14(3-4), 409-16.
Susumu Sasaki,Production of Lymphocytosis by Polysaccharide Polysulphates(Heparinoids) (1967) Nature, vol. 214, pp. 1041-1042.
G. Baggi et al.,Influence of Chondroitin Sulfate on the Process of Cicatrization of Experimentally Produced Cutaneous Injuries(1970) Minerva Chirurgica, 25(3), 181-184 (in MEDLINE, AN 71128533).
Bruce Alberts et al.,Molecular Biology of the Cell(1983) Garland Publishing, Inc., New York, p. 703.
Didier Letourneur et al.,In Vitro Stimulation of Human Endothelial Cells by Derivatized Dextrans(1993) In Vitro Cell. Dev. Biol.:Anim., 29A(1), 67-72.
Didier Letourneur et al.,Antiproliferative Capacity of Synthetic Dextrans on Smooth Muscle Cell Growth: The Model of Derivatized Dextrans as Heparin-like Polymers(1993) J. Biomater. Sci., Polym. Ed., 4(5), 431-44.
Marie-Agnès Leboucher-Durand et al.,Poly(β-malic acid)Derivatives with Unsaturated Lateral Groups: Epoxidation as Model Reactionof the Double Bonds Reactivity(1996) Reactive & Functional Polymers, vol. 31, No. 1, 57-65.
O. Maiga-Revel et al.,New Investigations on Heparin-like Derivatized Dextrans: CMDBS, Synergistic Role of Benzylamide and Sulfate Substituents in Anticoagulant Activity(1997) Carbohydrate Polymers, vol. 32, No. 2, 89-93.
C. Alexakis et al.,Regulation of the collagen phenotype expression of gamma-irradiated vascular smooth muscle cells by heparin mimetics(RGTA); (2004); Wiley Periodicals, Inc., pp. 594-602.
C. Alexakis, et al.Reversal of abnormal collagen production in Chron's disease intestinal biopsies treated with regenerating agents(2003).
Catherine Alexakis, et al.,Heparan mimetic regulates collagen expression and TGF-β1 distribution in gamma-irradiated human intestinal smooth muscle cells, (2001); The FASEB Journal, vol. 15; pp. 1546-1554.
Emmanuel Petit et al.,Controlled Sulfatation of Natural Anionic Bacterial Polysaccharides Can Yield Agents with Specific Regenerating Activity in Vivo; (Jul. 25, 2003); Biomacromolecules.
Hidetoshi Yamauchi, et al.New Agents for the treatment of infracted myocardium; (Sep. 8, 2000); The FASEB Journal.
Patricia Mestries, et al.,Specific RGTA increases collagen V expression by cultured aortic smooth muscle cells via activation and protection of transforming growth factor-β1,(2001); Matrix Biology, pp. 171-181.
Pascal Desgranges et al.,A substituted dextran enhances muscle fiber survival and regeneration in ischemic and denervated rat EDL muscle; (1999); The FASEB Journal; pp. 761-766.
Catherine Alexakis, et al.Structurally different RGTAs modulate collagen-type expression by cultured aortic smooth muscle cells via different pathways involving fibroblast growth factor-2 or transforming growth factor-β1(2004); The FASEB Journal.
Viviane Jeanbat-Mimaud, et al.,Bioactive functionalized polymer of malic acid for bone repair and muscle regeneration, (2000); J. Biomater. Sci. Polymer Edn. vol. 11, No. 9, pp. 979-991.
Alt, K. W. et al., “Evidence for Stone Age Cranial Surgery,”Nature, May 22, 1997, vol. 387, p. 360.
Biggs, R. et al., “Human Blood Coagulation Haemostasis and Thrombosis,”Blackwells, 1984, 3rd edition, p. 601 (abstract only—1 page).
Blanquaert, F. et al., “Heparan-Like Molecules Induce the Repair of Skull Defects,”Bone, Dec. 1995, vol. 17, No. 6, pp. 499-506.
Bostantjopoulou, S. et al., “Superoxide Dismutase Activity in Early and Advanced Parkinson's Disease,”Funct. Neurol., Mar.-Apr. 1997, vol. 12, No. 2, pp. 63-68 (abstract only—1 page).
D'Agnillo, F. et al., “Reduction of Hydoxyl Radical Generation in a Rat Hindlimb Model of Ischemia-Reperfusion Injury Using Crosslinked Hemoglobin-Supeoxide Dismutase-Catalase,”Artif. Cells Blood Substiti. Immobil. Biotechnol, Jan.-Mar. 1997, vol. 25, Nos. 1-2, pp. 163-180 (abstract only—1 page).
Fernández-Novoa, L. et al., “Effects of Anapsos on the Activity of the Enzyme Cu—Zn-Superoxide Dismutase in an Animal Model of Neuronal Degeneration,”Methods Find Exp. Clin. Pharmacol., Mar. 1997, vol. 19, No. 2, pp. 99-106 (abstract only—1 page).
Freund, M. et al., “The Mechanism of Action of Lymphokines—IX. The Enzymatic Basis of Hydrogen Peroxide Production by Lymphokine-Activated Macrophages,”The Journal of Immunology, Aug. 15, 1986, vol. 137, No. 4, pp. 1312-1318.
Graham, M. F. et al., “Isolation and Culture of Human Intestinal Smooth Muscle Cells,”Proceedings of the Society for Experimental Biology and Medicine, 1984, vol. 176, No. 4, pp. 503-507 (abstract only—1 page).
Guerin, P. et al., “Optically Active Poly (β-Malic-Acid),”Polymer Bulletin, 1985, vol. 14, pp. 187-192.
Hansen-Smith, F. M. et al., “Revascularization of the Freely Grafted Extensor Digitorum Longus Muscle in the Rat,”American Journal of Anatomy, 1980, vol. 158, pp. 65-82.
Ishai-Michaeli, R. et al., “Importance of Size and Sulfation of Heparin in Release of Basic Fibroblast Growth Factor from the Vascular Endothelium and Extracellular Matrix,”Biochemistry, 1992; vol. 31, pp. 2080-2088 (first page only).
Jun, T, et al., “Increased Superoxide Anion Production in Humans, a Possible Mechanism for the Pathogenesis of Hypertension,”Journal of Human Hypertension, 1996, vol. 10, No. 5, pp. 305-310 (abstract only—1 page).
Kandasamy, S. B. et al., &

Affiliated with

Also associated with

Rating

Process for treating fibroses with biocompatible polymer does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Process for treating fibroses with biocompatible polymer, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Process for treating fibroses with biocompatible polymer will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2774350